Comparison of carboplatin- and cisplatin-based concurrent chemoradiotherapy in locally advanced cervical cancer patients with morbidity risks

Oncologist

Volumn 18, Issue 7, 2013, Pages 843-849

  Ji Nam, Eun ^a   Lee, Maria ^a   Yim, Gawon ^a   Hoon Kim, Jae ^a   Kim, Sunghoon ^a   Wun Kim, Sang ^a   Wook Kim, Jae ^a   Kim, Young Tae ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Carboplatin; Cervical cancer; Chemoradiotherapy; Cisplatin

Indexed keywords

CARBOPLATIN; CISPLATIN; PACLITAXEL;

ADULT; AGED; ALLERGY; ANEMIA; ARTICLE; BRACHYTHERAPY; CHEMORADIOTHERAPY; CLINICAL EVALUATION; CONSTIPATION; CONTROLLED STUDY; CREATININE CLEARANCE; DIARRHEA; DISEASE COURSE; DYSPEPSIA; FATIGUE; FEMALE; FOLLOW UP; HEMATURIA; HERPES ZOSTER; HISTOLOGY; HUMAN; HUMAN TISSUE; IRRADIATION; KIDNEY FAILURE; KIDNEY FUNCTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MORBIDITY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL; PNEUMONIA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; THROMBOCYTOPENIA; UTERINE CERVIX CANCER; VOMITING; ADVERSE DRUG REACTION; CANCER STAGING; CLASSIFICATION; CLINICAL TRIAL; COMPARATIVE STUDY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

AGED; CARBOPLATIN; CISPLATIN; COMBINED MODALITY THERAPY; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PACLITAXEL; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 84880664901     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2012-0455     Document Type: Article

References (20)

1. Kim YT. Current status of cervical cancer and HPV infection in Korea. J Gynecol Oncol 2009;20:1-7.
2. Chemoradiotherapy for Cervical Cancer Metaanalysis Collaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: Individual patient data meta-analysis. Cochrane Database Syst Rev 2010:CD008285.
3. Rose PG, Bundy BN, Watkins EB et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999;340:1144-1153.
4. Keys HM, Bundy BN, Stehman FB et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999;340: 1154-1161.
5. Morris M, Eifel PJ, Lu J et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999;340:1137-1143.
6. Whitney CW, Sause W, Bundy BN et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999;17:1339-1348.
7. Muggia FM. Overview of carboplatin: Replacing, complementing, and extending the therapeutic horizons of cisplatin. Semin Oncol 1989; 16:7-13.
8. Schwachofer JH, Crooijmans RP, Hoogenhout J et al. Effectiveness in inhibition of recovery of cell survival by cisplatin and carboplatin: Influence of treatment sequence. Int J Radiat Oncol Biol Phys 1991;20:1235-1241.
9. Pekkola-Heino K, Kulmala J, Grenman R. Carboplatin-radiation interaction in squamous cell carcinoma cell lines. Arch Otolaryngol Head Neck Surg 1992;118:1312-1315.
10. Ozols RF, Bundy BN, Greer BE et al. Phase III trial of carboplatin and paclitaxel compared with cisplatinandpaclitaxel in patients with optimally resected stage III ovarian cancer: A Gynecologic Oncology Group study. J Clin Oncol 2003;21:3194-3200.
11. Corn BW, Hernandez E, Anderson L et al. Phase I/II study of concomitant irradiation and carboplatin for locally advanced carcinoma of the uterine cervix: An interim report. Am J Clin Oncol 1996;19: 317-321.
12. Dubay RA, Rose PG, O'Malley DM et al. Evaluation of concurrent and adjuvant carboplatin with radiation therapy for locally advanced cervical cancer. Gynecol Oncol 2004;94:121-124.
13. Duenas-Gonzalez A, Cetina L, Sanchez B et al. A phase I study of carboplatin concurrent with radiation in FIGO stage IIIB cervix uteri carcinoma. Int J Radiat Oncol Biol Phys 2003;56:1361-1365.
14. Higgins RV, Naumann WR, Hall JB et al. Concurrent carboplatin with pelvic radiation therapy in the primary treatment of cervix cancer. Gynecol Oncol 2003;89:499-503.
15. Micheletti E, La Face B, Bianchi E et al. Continuousinfusion of carboplatin during conventional radiotherapy treatment in advanced squamous carcinoma of the cervix uteri IIB-IIIB (UICC). A phase I/II and pharmacokinetic study Am J Clin Oncol 1997;20:613-620.
16. Veerasarn V, Lorvidhaya V, Kamnerdsupaphon P et al. A randomized phase III trial of concurrent chemoradiotherapy in locally advanced cervical cancer: Preliminary results. Gynecol Oncol 2007;104:15-23.
17. Kim YB, Cho JH, Keum KC et al. Concurrent chemoradiotherapy followed by adjuvant chemotherapy in uterine cervical cancer patients with high-risk factors. Gynecol Oncol 2007;104:58-63.
18. Therasse P, Arbuck SG, Eisenhauer EA et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92: 205-216.
19. Nag S, Chao C, Erickson B et al. The American Brachytherapy Society recommendations for low-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2002;52: 33-48.
20. Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic reviewandmeta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 2008;26:5802-5812.